| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |